drug

Rowasa

Marketedupdated 3mo ago

by Mylan Specialty LP

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying Rowasa

phase3A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitiswithdrawn
phase1Mesalamine 4 gm/60 mL Rectal Enemacompletedn=72
phase2Mesalazine Oral Suspension in Active Eosinophilic Esophagitiscompletedn=5

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

Rowasa

Marketedupdated 3mo ago

by Mylan Specialty LP

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying Rowasa

phase3A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitiswithdrawn
phase1Mesalamine 4 gm/60 mL Rectal Enemacompletedn=72
phase2Mesalazine Oral Suspension in Active Eosinophilic Esophagitiscompletedn=5

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

Rowasa

all catalysts(0)

Trials studying Rowasa

News(0)

Report a data issue

comments(0)

Rowasa

all catalysts(0)

Trials studying Rowasa

News(0)

Report a data issue

comments(0)